Hoyman Hong, MD
Physical Medicine and Rehabilitation · San Mateo
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 3
- 1 carrier
- Offices
- 6
Offices
6 locations · Hoyman Hong, MD A Prof Med Corp · Sutter Bay Medical Foundation
Hospitals listed: Mills-Peninsula Medical Center. That is not proof they admit you there this week.
Plans that list them
3 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Hong’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence A68161 · Current
Licensed to practise in California · since 1999 · expires 2027-02-28 · Wayne State University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Peninsula Medical CenterBurlingame, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.139, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.242, Oct 2024 – Sep 2025
See every measure and the patient survey for Peninsula Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.139 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.242 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.21 (0.27 to 2.15) · 1,258 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.81 (0.51 to 1.1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 155.44 (112.67 to 198.21) · 90 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.5 · 32 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 82 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 188 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9 · 473 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.8 · 342 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.4 · 485 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 3,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.4) · 6,904 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,052 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.41 (1.43 to 5.39) · 1,695 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.72 (0.17 to 3.28) · 665 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,545 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.1 (1.3 to 12.9) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.96 (2.63 to 9.29) · 653 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.08) · 418 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.14 (0 to 0.78) · 5,539 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 192 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.215 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.263 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.74 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 300 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19 · 702 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 1.2 · 207 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13.6 · 531 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 24.3 · 343 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 449 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.5 (2.8 to 7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.6 (6.7 to 13.7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 189 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11 · 45 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 117 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.7 to 17.2) · 584 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 764 cases | No different | Jan 2024 – Dec 2024 |
What patients said (523 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$125,422
Medicare paid this office $125,422 for 146 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 132 | $76,499 | $111 |
| Chronic care management services for two or more chronic conditions, first 30 minutes provided personally by health care professional, per calendar month | 109 | $27,199 | $71 |
| New patient visit (45+ min) | 37 | $5,405 | $146 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 15 | $1,832 | $115 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 15 | $689 | $43 |
See all 7 services
| Return visit (30+ min) | 132 | $76,499 | $111 |
| Chronic care management services for two or more chronic conditions, first 30 minutes provided personally by health care professional, per calendar month | 109 | $27,199 | $71 |
| New patient visit (45+ min) | 37 | $5,405 | $146 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 15 | $1,832 | $115 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 15 | $689 | $43 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 19 | $56 | None |
| Injection, bupivicaine, not otherwise specified, 0.5 mg | 20 | $1 | None |
Who their Medicare patients are
146 Original Medicare patients in 2024. Average age 75 · Women 58% · Health risk score 1.14. At or below the middle of the specialty; the typical physical medicine and rehabilitation clinician is at 1.53.
Conditions among them: High blood pressure 75% · Coronary heart disease 27% · Diabetes 25% · Depression 22% · Chronic kidney disease 21% · Atrial fibrillation 19% · Cancer 16% · Heart failure 15% · COPD 13%.
The office billed $382,678, Medicare allowed $163,228 and paid $125,422; for 2,557 services of 36 kinds; $2,469 of it was for drugs given in the office and $122,954 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 146 | 2,557 | 75 | 1.14 | $382,678 | $125,422 |
| 2023 | 143 | 5,743 | 75 | 1.09 | $391,268 | $160,480 |
| 2022 | 118 | 6,428 | 73 | 1.18 | $385,838 | $161,365 |
| 2021 | 110 | 6,441 | 73 | 1.03 | $328,249 | $146,163 |
| 2020 | 134 | 6,916 | 73 | 1.22 | $293,515 | $126,183 |
| 2019 | 191 | 7,334 | 74 | 1.16 | $337,661 | $121,010 |
| 2018 | 150 | 3,532 | 72 | 1.11 | $216,902 | $71,654 |
| 2017 | 155 | 2,506 | 71 | 1.15 | $216,402 | $61,457 |
| 2016 | 183 | 1,719 | 71 | 1.11 | $321,090 | $85,095 |
| 2015 | 171 | 1,005 | 70 | 1.03 | $224,163 | $60,105 |
| 2014 | 174 | 750 | 72 | 1.01 | $231,192 | $54,284 |
| 2013 | 150 | 832 | 72 | 1.22 | $259,607 | $56,949 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 11 services
| Return visit (30+ min) | 123 | $81,516 | $107 |
| Chronic care management services for two or more chronic conditions, first 30 minutes provided personally by health care professional, per calendar month | 109 | $28,950 | $70 |
| New patient visit (45+ min) | 38 | $5,327 | $140 |
| Aspiration and/or injection of fluid from large joint | 12 | $2,654 | $70 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 22 | $2,618 | $105 |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | 14 | $1,221 | $81 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 19 | $1,191 | $48 |
| Injection of trigger points, 3 or more muscles | 14 | $1,001 | $50 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 29 | $523 | $10 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 23 | $83 | None |
| Injection, dexamethasone sodium phosphate, 1 mg | 12 | $5 | None |
2022: 16 services
| Return visit (30+ min) | 112 | $70,986 | $110 |
| Chronic care management services for two or more chronic conditions, first 30 minutes provided personally by health care professional, per calendar month | 105 | $31,034 | $71 |
| Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | 95 | $5,447 | $12 |
| New patient visit (45+ min) | 21 | $3,070 | $146 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | 11 | $2,786 | $164 |
| Aspiration and/or injection of fluid from large joint | 13 | $2,279 | $69 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 16 | $2,014 | $112 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 15 | $1,786 | $99 |
| Injection of trigger points, 3 or more muscles | 15 | $1,230 | $49 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 15 | $1,019 | $49 |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | 14 | $1,004 | $59 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 14 | $880 | $55 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | 11 | $838 | $49 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 39 | $684 | $10 |
| Injection of trigger points, 1-2 muscles | 12 | $533 | $38 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 31 | $173 | None |
2021: 11 services
| Return visit (30+ min) | 106 | $65,209 | $111 |
| Chronic care management services for two or more chronic conditions, first 30 minutes provided personally by health care professional, per calendar month | 109 | $36,490 | $69 |
| Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | 108 | $7,019 | $13 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 17 | $2,105 | $105 |
| Aspiration and/or injection of fluid from large joint | 16 | $1,826 | $63 |
| New patient visit (45+ min) | 11 | $1,489 | $135 |
| Injection of trigger points, 3 or more muscles | 13 | $1,255 | $50 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 16 | $1,181 | $45 |
| Injection of trigger points, 1-2 muscles | 14 | $669 | $37 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 28 | $380 | $11 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 28 | $174 | None |
2020: 12 services
| Return visit (30+ min) | 120 | $40,053 | $91 |
| Chronic care management services for two or more chronic conditions, first 30 minutes provided personally by health care professional, per calendar month | 112 | $31,996 | $71 |
| Short return visit (20+ min) | 45 | $7,340 | $68 |
| Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | 89 | $3,346 | $13 |
| Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes | 72 | $2,681 | $29 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 16 | $1,830 | $102 |
| New patient visit (45+ min) | 13 | $1,581 | $122 |
| Aspiration and/or injection of fluid from large joint | 12 | $1,314 | $57 |
| Injection of trigger points, 1-2 muscles | 13 | $987 | $47 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 14 | $816 | $48 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 26 | $345 | $10 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 22 | $126 | None |
2019: 15 services
| Return visit (30+ min) | 149 | $37,829 | $94 |
| Botox | 11 | $25,085 | None |
| New patient visit (45+ min) | 85 | $12,066 | $142 |
| Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes | 119 | $9,100 | $30 |
| Return visit (30+ min) | 27 | $7,164 | $66 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | 12 | $4,147 | $197 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 24 | $2,815 | $101 |
| Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes | 26 | $2,814 | $28 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | 12 | $2,060 | $51 |
| Injection of trigger points, 1-2 muscles | 22 | $1,815 | $48 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 23 | $1,419 | $46 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 12 | $1,059 | $81 |
| Aspiration and/or injection of fluid from large joint | 12 | $1,026 | $57 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 39 | $628 | $10 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 35 | $133 | None |
2018: 10 services
| Return visit (30+ min) | 78 | $17,588 | $88 |
| Return visit (30+ min) | 52 | $11,000 | $64 |
| New patient visit (45+ min) | 33 | $4,435 | $134 |
| Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes | 43 | $3,964 | $27 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 23 | $2,846 | $98 |
| Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes | 30 | $2,295 | $29 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 22 | $1,246 | $43 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 50 | $655 | $10 |
| Aspiration and/or injection of fluid from large joint | 11 | $341 | $26 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 15 | $104 | None |
2017: 15 services
| Return visit (30+ min) | 67 | $14,243 | $64 |
| Return visit (30+ min) | 41 | $8,545 | $84 |
| Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes | 62 | $5,205 | $27 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | 13 | $3,068 | $192 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 23 | $2,601 | $96 |
| New patient visit (45+ min) | 16 | $2,073 | $130 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | 13 | $1,694 | $53 |
| Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes | 19 | $1,374 | $27 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 23 | $1,156 | $43 |
| New patient visit (45+ min) | 11 | $1,134 | $103 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 59 | $963 | $10 |
| Injection of contrast for imaging of hip joint | 13 | $808 | $58 |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | 11 | $806 | $73 |
| Aspiration and/or injection of fluid from large joint | 20 | $776 | $28 |
| Review by radiologist of hip joint image | 13 | $333 | $24 |
2016: 19 services
| Return visit (30+ min) | 91 | $19,012 | $64 |
| Return visit (30+ min) | 54 | $14,480 | $92 |
| Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes | 74 | $5,224 | $28 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 37 | $4,789 | $100 |
| Moderate sedation services by physician also performing a procedure, patient 5 years of age or older, first 30 minutes | 72 | $4,461 | $36 |
| New patient visit (45+ min) | 39 | $4,131 | $106 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | 14 | $3,325 | $208 |
| New patient visit (45+ min) | 19 | $2,573 | $135 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 20 | $2,109 | $88 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 33 | $2,084 | $44 |
| Injection of anesthetic and/or steroid drug into upper or middle spine nerve root using imaging guidance, single level | 12 | $1,720 | $115 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | 14 | $1,685 | $54 |
| Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes | 13 | $1,180 | $30 |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | 14 | $1,130 | $71 |
| Short return visit (20+ min) | 22 | $982 | $41 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 16 | $970 | $54 |
| Injection of contrast for imaging of hip joint | 14 | $831 | $59 |
| Aspiration and/or injection of fluid from large joint | 19 | $791 | $28 |
| Review by radiologist of hip joint image | 12 | $293 | $24 |
2015: 9 services
| Return visit (30+ min) | 74 | $14,581 | $65 |
| Return visit (30+ min) | 46 | $10,460 | $92 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 41 | $5,455 | $101 |
| New patient visit (45+ min) | 23 | $3,252 | $141 |
| Moderate sedation services by physician also performing a procedure, patient 5 years of age or older, first 30 minutes | 60 | $3,015 | $36 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 35 | $2,114 | $46 |
| New patient visit (45+ min) | 19 | $2,069 | $109 |
| Muscle electrical test | 11 | $1,288 | $86 |
| Aspiration and/or injection of fluid from large joint | 15 | $400 | $25 |
2014: 10 services
| Return visit (30+ min) | 81 | $14,449 | $64 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 50 | $6,347 | $98 |
| Return visit (30+ min) | 34 | $5,783 | $86 |
| New patient visit (45+ min) | 30 | $3,245 | $108 |
| New patient visit (45+ min) | 21 | $2,865 | $136 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 50 | $2,719 | $45 |
| Moderate sedation services by physician also performing a procedure, patient 5 years of age or older, first 30 minutes | 49 | $2,385 | $35 |
| Aspiration and/or injection of fluid from large joint | 14 | $697 | $37 |
| Fluoroscopic guidance for spine or back muscle injection | 17 | $416 | $24 |
| Injection of trigger points, 1-2 muscles | 12 | $259 | $20 |
2013: 11 services
| Return visit (30+ min) | 62 | $12,146 | $63 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 47 | $6,471 | $104 |
| Return visit (30+ min) | 28 | $4,887 | $94 |
| New patient visit (45+ min) | 32 | $3,396 | $106 |
| New patient visit (45+ min) | 21 | $2,966 | $141 |
| Fluoroscopic guidance for spine or back muscle injection | 66 | $2,167 | $25 |
| Moderate sedation services by physician also performing a procedure, patient 5 years of age or older, first 30 minutes | 39 | $2,041 | $36 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 33 | $1,777 | $44 |
| Radiological supervision and interpretation x-ray of covering of spinal cord | 44 | $1,718 | $32 |
| Muscle electrical test | 13 | $1,576 | $79 |
| Short return visit (20+ min) | 21 | $1,122 | $42 |
Drugs they prescribed that Part D paid
$197,576
Pharmacies billed $197,576 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 57% of their Part D prescriptions (769 of 1,355) in 2024. A higher opioid share than 9 in 10 peers; the typical physical medicine and rehabilitation clinician is at 12%. Long-acting opioids: 41% of their opioid prescriptions.
1,230 generic and 125 brand-name prescriptions · $197,576 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Oxycontin | 30 | $86,384 | $2,879 |
| Xtampza Er | 53 | $44,494 | $840 |
| Buprenorphine | 56 | $12,450 | $222 |
| Hydrocodone-Acetaminophen | 265 | $7,268 | $27 |
| Butrans | 13 | $6,673 | $513 |
See all 26 drugs
| Oxycontin | 30 | $86,384 | $2,879 |
| Xtampza Er | 53 | $44,494 | $840 |
| Buprenorphine | 56 | $12,450 | $222 |
| Hydrocodone-Acetaminophen | 265 | $7,268 | $27 |
| Butrans | 13 | $6,673 | $513 |
| Fentanyl | 40 | $4,659 | $116 |
| Gabapentin | 146 | $2,322 | $16 |
| Morphine Sulfate Er | 79 | $1,964 | $25 |
| Oxycodone-Acetaminophen | 78 | $1,191 | $15 |
| Lidocaine | 20 | $1,179 | $59 |
| Pregabalin | 51 | $1,131 | $22 |
| Tramadol Hcl Er | 19 | $921 | $48 |
| Cyclobenzaprine | 48 | $615 | $13 |
| Oxycodone | 58 | $599 | $10 |
| Duloxetine | 14 | $548 | $39 |
| Baclofen | 30 | $430 | $14 |
| Nortriptyline | 13 | $398 | $31 |
| Methadone | 21 | $392 | $19 |
| Diclofenac | 22 | $278 | $13 |
| Topiramate | 16 | $234 | $15 |
| Nabumetone | 19 | $221 | $12 |
| Hydromorphone | 29 | $193 | $7 |
| Tizanidine | 24 | $163 | $7 |
| Meloxicam | 73 | $139 | $2 |
| Tramadol | 18 | $94 | $5 |
| Zolpidem | 16 | $6 | $0 |
Year by year
| 2024 | 1,355 | 146 | 57% (769) | 9% | $197,576 |
| 2023 | 1,561 | 155 | 56% (877) | None | $219,064 |
| 2022 | 1,266 | 134 | 59% (741) | 12% | $147,559 |
| 2021 | 973 | 96 | 52% (509) | 14% | $160,240 |
| 2020 | 1,265 | 156 | 55% (694) | 14% | $181,338 |
| 2019 | 1,231 | 145 | 52% (635) | 18% | $189,073 |
| 2018 | 1,189 | 129 | 52% (614) | 22% | $162,706 |
| 2017 | 1,137 | 120 | 55% (628) | 18% | $116,006 |
| 2016 | 1,045 | 127 | 51% (534) | 19% | $130,360 |
| 2015 | 926 | 122 | 53% (490) | 17% | $93,404 |
| 2014 | 870 | 112 | 49% (425) | 20% | $78,206 |
| 2013 | 815 | 112 | 51% (419) | 18% | $63,724 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 27 drugs
| Oxycontin | 33 | $79,220 | $2,401 |
| Xtampza Er | 46 | $45,344 | $986 |
| Buprenorphine | 65 | $18,453 | $284 |
| Butrans | 13 | $10,858 | $835 |
| Hydrocodone-Acetaminophen | 325 | $9,813 | $30 |
| Fentanyl | 55 | $8,698 | $158 |
| Pregabalin | 71 | $3,310 | $47 |
| Morphine Sulfate Er | 64 | $2,729 | $43 |
| Gabapentin | 150 | $2,488 | $17 |
| Oxycodone | 70 | $2,227 | $32 |
| Oxycodone-Acetaminophen | 78 | $2,010 | $26 |
| Lidocaine | 12 | $1,362 | $113 |
| Celecoxib | 19 | $1,326 | $70 |
| Methadone | 24 | $819 | $34 |
| Cyclobenzaprine | 58 | $754 | $13 |
| Baclofen | 40 | $744 | $19 |
| Nortriptyline | 33 | $706 | $21 |
| Duloxetine | 27 | $519 | $19 |
| Nabumetone | 12 | $517 | $43 |
| Diclofenac | 22 | $427 | $19 |
| Tramadol | 46 | $369 | $8 |
| Meloxicam | 64 | $319 | $5 |
| Ropinirole | 12 | $171 | $14 |
| Hydromorphone | 25 | $141 | $6 |
| Diazepam | 15 | $135 | $9 |
| Topiramate | 19 | $95 | $5 |
| Zolpidem | 14 | $19 | $1 |
2022: 24 drugs
| Oxycontin | 22 | $31,137 | $1,415 |
| Xtampza Er | 31 | $25,442 | $821 |
| Buprenorphine | 57 | $16,672 | $292 |
| Fentanyl | 66 | $9,236 | $140 |
| Butrans | 11 | $8,750 | $795 |
| Hydrocodone-Acetaminophen | 256 | $6,937 | $27 |
| Savella | 14 | $6,582 | $470 |
| Gabapentin | 121 | $3,644 | $30 |
| Oxycodone | 84 | $3,442 | $41 |
| Morphine Sulfate Er | 28 | $1,973 | $70 |
| Oxycodone-Acetaminophen | 47 | $1,853 | $39 |
| Pregabalin | 47 | $1,748 | $37 |
| Celecoxib | 26 | $1,396 | $54 |
| Methadone | 31 | $893 | $29 |
| Cyclobenzaprine | 56 | $607 | $11 |
| Tramadol | 57 | $554 | $10 |
| Baclofen | 14 | $415 | $30 |
| Nortriptyline | 31 | $408 | $13 |
| Duloxetine | 19 | $320 | $17 |
| Diclofenac | 19 | $313 | $16 |
| Topiramate | 19 | $310 | $16 |
| Meloxicam | 36 | $273 | $8 |
| Temazepam | 11 | $73 | $7 |
| Diazepam | 17 | $69 | $4 |
2021: 25 drugs
| Oxycontin | 22 | $28,590 | $1,300 |
| Xtampza Er | 19 | $20,728 | $1,091 |
| Nucynta | 13 | $13,628 | $1,048 |
| Butrans | 12 | $8,889 | $741 |
| Savella | 15 | $6,639 | $443 |
| Buprenorphine | 25 | $6,187 | $247 |
| Belbuca | 11 | $6,037 | $549 |
| Fentanyl | 42 | $5,001 | $119 |
| Hydrocodone-Acetaminophen | 181 | $4,973 | $27 |
| Morphine Sulfate Er | 25 | $3,374 | $135 |
| Gabapentin | 110 | $2,247 | $20 |
| Methadone | 25 | $1,324 | $53 |
| Oxycodone-Acetaminophen | 33 | $1,269 | $38 |
| Pregabalin | 41 | $1,129 | $28 |
| Oxycodone | 41 | $1,070 | $26 |
| Baclofen | 27 | $729 | $27 |
| Tramadol | 31 | $614 | $20 |
| Celecoxib | 12 | $570 | $48 |
| Duloxetine | 20 | $443 | $22 |
| Nortriptyline | 21 | $317 | $15 |
| Cyclobenzaprine | 46 | $304 | $7 |
| Trazodone | 16 | $190 | $12 |
| Diclofenac | 12 | $183 | $15 |
| Meloxicam | 14 | $84 | $6 |
| Zolpidem | 23 | $78 | $3 |
2020: 26 drugs
| Oxycontin | 30 | $29,464 | $982 |
| Nucynta Er | 29 | $19,014 | $656 |
| Nucynta | 13 | $13,201 | $1,015 |
| Butrans | 20 | $12,335 | $617 |
| Hydrocodone-Acetaminophen | 241 | $6,567 | $27 |
| Fentanyl | 51 | $6,515 | $128 |
| Savella | 12 | $5,059 | $422 |
| Buprenorphine | 21 | $4,458 | $212 |
| Gabapentin | 164 | $3,611 | $22 |
| Oxymorphone Hcl Er | 17 | $3,357 | $197 |
| Morphine Sulfate Er | 53 | $3,331 | $63 |
| Oxycodone-Acetaminophen | 58 | $2,703 | $47 |
| Pregabalin | 52 | $2,268 | $44 |
| Oxycodone | 47 | $1,759 | $37 |
| Methadone | 30 | $1,203 | $40 |
| Baclofen | 21 | $979 | $47 |
| Tramadol | 43 | $715 | $17 |
| Duloxetine | 31 | $684 | $22 |
| Cyclobenzaprine | 48 | $476 | $10 |
| Nortriptyline | 21 | $421 | $20 |
| Hydromorphone | 12 | $358 | $30 |
| Piroxicam | 13 | $336 | $26 |
| Celecoxib | 11 | $334 | $30 |
| Tizanidine | 15 | $297 | $20 |
| Amitriptyline | 13 | $226 | $17 |
| Zolpidem | 23 | $139 | $6 |
2019: 26 drugs
| Nucynta Er | 33 | $19,960 | $605 |
| Lyrica | 39 | $18,187 | $466 |
| Oxycontin | 29 | $13,212 | $456 |
| Nucynta | 14 | $11,547 | $825 |
| Fentanyl | 50 | $8,674 | $173 |
| Butrans | 16 | $8,561 | $535 |
| Morphabond Er | 13 | $7,425 | $571 |
| Hydrocodone-Acetaminophen | 214 | $6,706 | $31 |
| Oxycodone-Acetaminophen | 69 | $3,043 | $44 |
| Gabapentin | 135 | $2,995 | $22 |
| Morphine Sulfate Er | 40 | $2,369 | $59 |
| Duloxetine | 39 | $1,593 | $41 |
| Diclofenac | 18 | $1,345 | $75 |
| Oxycodone | 41 | $1,290 | $31 |
| Pregabalin | 23 | $1,181 | $51 |
| Dextroamphetamine-Amphet Er | 11 | $958 | $87 |
| Baclofen | 16 | $713 | $45 |
| Tramadol | 34 | $668 | $20 |
| Cyclobenzaprine | 47 | $616 | $13 |
| Acetaminophen-Codeine | 25 | $576 | $23 |
| Methadone | 23 | $565 | $25 |
| Zolpidem | 34 | $322 | $9 |
| Tizanidine | 15 | $290 | $19 |
| Meloxicam | 41 | $200 | $5 |
| Diazepam | 15 | $151 | $10 |
| Escitalopram | 12 | $77 | $6 |
2018: 28 drugs
| Lyrica | 67 | $29,325 | $438 |
| Oxycontin | 34 | $15,192 | $447 |
| Fentanyl | 78 | $10,271 | $132 |
| Movantik | 24 | $9,044 | $377 |
| Morphabond Er | 14 | $8,907 | $636 |
| Nucynta | 13 | $8,028 | $618 |
| Nucynta Er | 19 | $7,237 | $381 |
| Hydrocodone-Acetaminophen | 206 | $5,853 | $28 |
| Buprenorphine | 13 | $4,532 | $349 |
| Zorvolex | 12 | $4,149 | $346 |
| Savella | 11 | $3,827 | $348 |
| Oxycodone-Acetaminophen | 61 | $3,663 | $60 |
| Gabapentin | 128 | $2,107 | $16 |
| Duloxetine | 21 | $1,745 | $83 |
| Oxycodone | 51 | $1,701 | $33 |
| Morphine Sulfate Er | 23 | $1,605 | $70 |
| Dextroamphetamine-Amphet Er | 11 | $1,287 | $117 |
| Lidocaine | 11 | $1,268 | $115 |
| Methadone | 34 | $713 | $21 |
| Tramadol | 28 | $521 | $19 |
| Cyclobenzaprine | 28 | $512 | $18 |
| Baclofen | 15 | $455 | $30 |
| Diclofenac | 21 | $401 | $19 |
| Topiramate | 17 | $329 | $19 |
| Acetaminophen-Codeine | 19 | $324 | $17 |
| Zolpidem | 30 | $215 | $7 |
| Diazepam | 21 | $144 | $7 |
| Escitalopram | 11 | $78 | $7 |
2017: 24 drugs
| Oxycontin | 57 | $23,907 | $419 |
| Lyrica | 27 | $13,807 | $511 |
| Butrans | 23 | $9,177 | $399 |
| Fentanyl | 89 | $8,383 | $94 |
| Hydrocodone-Acetaminophen | 179 | $4,326 | $24 |
| Movantik | 12 | $3,835 | $320 |
| Savella | 11 | $3,504 | $319 |
| Oxycodone-Acetaminophen | 59 | $2,970 | $50 |
| Morphine Sulfate Er | 45 | $2,830 | $63 |
| Oxycodone | 62 | $1,642 | $26 |
| Gabapentin | 118 | $1,415 | $12 |
| Methadone | 40 | $976 | $24 |
| Duloxetine | 16 | $650 | $41 |
| Baclofen | 20 | $630 | $31 |
| Tramadol | 31 | $566 | $18 |
| Cyclobenzaprine | 36 | $534 | $15 |
| Diclofenac | 33 | $533 | $16 |
| Nabumetone | 12 | $370 | $31 |
| Piroxicam | 14 | $283 | $20 |
| Acetaminophen-Codeine | 12 | $276 | $23 |
| Zolpidem | 34 | $205 | $6 |
| Topiramate | 14 | $129 | $9 |
| Diazepam | 29 | $96 | $3 |
| Meloxicam | 18 | $77 | $4 |
2016: 22 drugs
| Oxycontin | 68 | $27,518 | $405 |
| Lyrica | 34 | $14,182 | $417 |
| Fentanyl | 80 | $10,927 | $137 |
| Hydrocodone-Acetaminophen | 123 | $5,607 | $46 |
| Suboxone | 11 | $5,224 | $475 |
| Zorvolex | 12 | $3,517 | $293 |
| Morphine Sulfate Er | 37 | $3,325 | $90 |
| Oxycodone-Acetaminophen | 46 | $2,895 | $63 |
| Gabapentin | 149 | $2,350 | $16 |
| Oxycodone | 50 | $2,017 | $40 |
| Methadone | 39 | $987 | $25 |
| Acetaminophen-Codeine | 16 | $695 | $43 |
| Baclofen | 24 | $650 | $27 |
| Tramadol | 30 | $642 | $21 |
| Piroxicam | 11 | $628 | $57 |
| Duloxetine | 13 | $511 | $39 |
| Diclofenac | 26 | $368 | $14 |
| Tramadol Hcl Er | 11 | $264 | $24 |
| Zolpidem | 31 | $248 | $8 |
| Omeprazole | 14 | $214 | $15 |
| Diazepam | 31 | $156 | $5 |
| Meloxicam | 18 | $134 | $7 |
2015: 21 drugs
| Oxycontin | 61 | $21,720 | $356 |
| Fentanyl | 63 | $10,375 | $165 |
| Hydrocodone-Acetaminophen | 131 | $5,459 | $42 |
| Oxycodone-Acetaminophen | 43 | $4,720 | $110 |
| Lyrica | 15 | $4,253 | $284 |
| Zorvolex | 15 | $3,521 | $235 |
| Gabapentin | 155 | $3,463 | $22 |
| Lidocaine | 11 | $3,209 | $292 |
| Morphine Sulfate Er | 21 | $1,781 | $85 |
| Dextroamphetamine-Amphet Er | 11 | $1,443 | $131 |
| Oxycodone | 42 | $1,435 | $34 |
| Methadone | 59 | $1,289 | $22 |
| Duloxetine | 17 | $1,140 | $67 |
| Nabumetone | 11 | $387 | $35 |
| Tramadol | 35 | $347 | $10 |
| Baclofen | 20 | $335 | $17 |
| Topiramate | 19 | $257 | $14 |
| Diclofenac | 11 | $166 | $15 |
| Nortriptyline | 14 | $96 | $7 |
| Zolpidem | 15 | $88 | $6 |
| Meloxicam | 14 | $58 | $4 |
2014: 19 drugs
| Oxycontin | 50 | $15,968 | $319 |
| Fentanyl | 50 | $12,467 | $249 |
| Lyrica | 23 | $7,891 | $343 |
| Hydrocodone-Acetaminophen | 110 | $4,435 | $40 |
| Gabapentin | 191 | $4,066 | $21 |
| Oxycodone-Acetaminophen | 42 | $3,496 | $83 |
| Duloxetine | 15 | $2,096 | $140 |
| Oxycodone | 36 | $1,740 | $48 |
| Dextroamphetamine-Amphet Er | 12 | $1,586 | $132 |
| Methadone | 52 | $1,137 | $22 |
| Piroxicam | 18 | $957 | $53 |
| Morphine Sulfate Er | 23 | $834 | $36 |
| Voltaren | 11 | $520 | $47 |
| Diclofenac | 17 | $440 | $26 |
| Tizanidine | 11 | $433 | $39 |
| Tramadol | 32 | $427 | $13 |
| Baclofen | 24 | $261 | $11 |
| Topiramate | 13 | $145 | $11 |
| Zolpidem | 14 | $66 | $5 |
2013: 19 drugs
| Fentanyl | 61 | $12,825 | $210 |
| Lidoderm | 13 | $5,189 | $399 |
| Oxycontin | 19 | $5,099 | $268 |
| Lyrica | 15 | $4,758 | $317 |
| Cymbalta | 11 | $4,683 | $426 |
| Gabapentin | 146 | $3,646 | $25 |
| Hydrocodone-Acetaminophen | 121 | $2,668 | $22 |
| Oxycodone Hcl-Acetaminophen | 36 | $2,651 | $74 |
| Oxycodone | 54 | $1,941 | $36 |
| Dextroamphetamine-Amphetamine | 11 | $1,459 | $133 |
| Methadone | 51 | $935 | $18 |
| Piroxicam | 13 | $819 | $63 |
| Diclofenac | 24 | $745 | $31 |
| Topiramate | 26 | $727 | $28 |
| Carisoprodol | 14 | $287 | $20 |
| Baclofen | 25 | $275 | $11 |
| Tramadol | 29 | $275 | $9 |
| Zolpidem | 16 | $81 | $5 |
| Diazepam | 11 | $50 | $5 |
Money from drug and device companies
$1,160 in 2025
| 2025 | 6 | 18 | None | $1,160 |
| 2024 | 7 | 18 | None | $548 |
| 2023 | 3 | 10 | None | $203 |
| 2022 | 5 | 13 | None | $232 |
| 2021 | 5 | 10 | None | $206 |
| 2020 | 7 | 10 | None | $167 |
| 2019 | 15 | 62 | None | $837 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Stryker | Mild Device Kit | $887 | 8 payments
|
| Collegium Pharmaceutical | Belbuca | $102 | 5 payments
|
| Merz Pharmaceuticals | Xeomin | $95 | 2 payments
|
| Abbvie | Botox | $31 | 1 payment
|
| Vertex Pharmaceuticals | None | $31 | 1 payment
|
| Salix Pharmaceuticals a division of Bausch Health US | Relistor | $15 | 1 payment
|
See all 18 published payments
| Vertex Pharmaceuticals | Meals · 2025-09-04 | None | $31 |
| Merz Pharmaceuticals | Meals · 2025-09-03 | Xeomin | $49 |
| Collegium Pharmaceutical | Meals · 2025-07-23 | Belbuca | $19 |
| Merz Pharmaceuticals | Meals · 2025-06-18 | Xeomin | $47 |
| Collegium Pharmaceutical | Meals · 2025-06-11 | Belbuca | $22 |
| Collegium Pharmaceutical | Meals · 2025-06-11 | Belbuca | $16 |
| Abbvie | Meals · 2025-05-16 | Botox | $31 |
| Stryker | Travel · 2025-04-19 | Mild Device Kit | $244 |
| Stryker | Travel · 2025-03-18 | Mild Device Kit | $37 |
| Stryker | Travel · 2025-03-15 | Mild Device Kit | $31 |
| Stryker | Meals · 2025-03-15 | Mild Device Kit | $24 |
| Stryker | Meals · 2025-03-15 | Mild Device Kit | $28 |
| Stryker | Meals · 2025-03-14 | Mild Device Kit | $173 |
| Stryker | Meals · 2025-03-13 | Mild Device Kit | $2 |
| Collegium Pharmaceutical | Meals · 2025-03-12 | Belbuca | $23 |
| Stryker | Travel · 2025-02-21 | Mild Device Kit | $346 |
| Collegium Pharmaceutical | Meals · 2025-01-28 | Belbuca | $22 |
| Salix Pharmaceuticals a division of Bausch Health US | Meals · 2025-01-14 | Relistor | $15 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $548
| Stryker | Mild Device Kit | $185 | 2 payments
|
| Collegium Pharmaceutical | Belbuca | $92 | 4 payments
|
| Pacira Pharmaceuticals | Zilretta | $90 | 3 payments
|
| Salix Pharmaceuticals a division of Bausch Health US | Relistor | $75 | 4 payments
|
| Saluda Medical Americas | Evoke | $46 | 2 payments
|
| Pfizer | Nurtec Odt | $40 | 2 payments
|
| Bioventus | Durolane | $21 | 1 payment
|
2023: $203
| Collegium Pharmaceutical | Belbuca | $133 | 7 payments
|
| Pacira Pharmaceuticals | Zilretta | $56 | 2 payments
|
| Bioventus | Durolane | $14 | 1 payment
|
2022: $232
| Collegium Pharmaceutical | Xtampza | $130 | 8 payments
|
| Salix Pharmaceuticals a division of Bausch Health US | Relistor | $43 | 2 payments
|
| Pacira Pharmaceuticals | Iovera | $25 | 1 payment
|
| Fidia Pharma USA | Hymovis | $21 | 1 payment
|
| RedHill Biopharma | Movantik | $13 | 1 payment
|
2021: $206
| Collegium Pharmaceutical | Xtampza | $78 | 4 payments
|
| Alfasigma USA | None | $54 | 2 payments
|
| BioDelivery Sciences International | Belbuca | $36 | 2 payments
|
| AbbVie | Ubrelvy | $23 | 1 payment
|
| Hikma Pharmaceuticals USA | Kloxxado | $15 | 1 payment
|
2020: $167
| Biodelivery Sciences International | Belbuca | $48 | 3 payments
|
| Collegium Pharmaceutical | Xtampza | $38 | 2 payments
|
| Indivior | Sublocade | $21 | 1 payment
|
| Novartis Pharmaceuticals | Aimovig | $20 | 1 payment
|
| Nevro | Senza Spinal Cord Stimulation System | $20 | 1 payment
|
| Pfizer | Lyrica | $14 | 1 payment
|
| Electronic Waveform Lab | None | $7 | 1 payment
|
2019: $837
| Collegium Pharmaceutical | Xtampza | $170 | 30 payments
|
| BioDelivery Sciences International | Belbuca | $162 | 5 payments
|
| Novartis Pharmaceuticals | Aimovig | $72 | 4 payments
|
| Pfizer | Lyrica | $70 | 4 payments
|
| Assertio Therapeutics | Gralise | $65 | 3 payments
|
| Amgen | Aimovig | $50 | 2 payments
|
| Scilex Pharmaceuticals | Ztlido 30 Pouch in 1 Carton 1 Patch in 1 Pouch | $46 | 2 payments
|
| Nevro | Senza Spinal Cord Stimulation System | $44 | 2 payments
|
| Horizon Therapeutics plc | Duexis | $34 | 2 payments
|
| Electronic Waveform Lab | None | $33 | 3 payments
|
| Abbott Laboratories | Neuromodulation Dspsbls and Accs | $25 | 1 payment
|
| Salix Pharmaceuticals a division of Bausch Health US | Lucemyra | $22 | 1 payment
|
| Kaleo | Evzio | $16 | 1 payment
|
| Bioventus | Durolane | $16 | 1 payment
|
| Lilly USA | Emgality | $13 | 1 payment
|
Professional record
- NPI
- 1124120845
- Licence
- CA A68161California A68161: Current · expires 2027-02-28
- Trained
- Wayne State University School of Medicine, 1997
- Group
- Hoyman Hong, MD A Prof Med Corp · Sutter Bay Medical Foundation
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 2081P2900X (2081P2900X)
- Mailing address
- 34 N San Mateo Dr, Suite #2, San Mateo, CA, 94401
- NPI first listed
- 2006-09-02
- NPI last updated
- 2021-09-29
- NPI record certified
- 2021-09-29
This is when the NPI record was last certified, not a medical board exam.